Kelvin Chan

Dr Kelvin Chan is a medical oncologist at the Sunnybrook Odette Cancer Centre, an Assistant Professor at the University of Toronto, and an associate scientist at the Sunnybrook Research Institute. He specializes in GI oncology and Head and Neck oncology.

As a clinical epidemiologist and biostatistician, Dr Chan's research interests include health services research, health technology assessment, meta-analysis including network meta-analysis, cost-effectiveness analyses, and statistical methods research in health economics. He is the Co-Director at the Canadian Centre for Applied Research in Cancer Control (ARCC), funded by the Canadian Cancer Society (CCS).

Professionally, Dr Chan has an interest in cancer drug reimbursement related issues. He is a member of multiple provincial and national committees related to cancer drug assessments and recommendations including the Committee to Evaluate Drug (CED), the Ontario Steering Committee of Cancer Drugs (OSCCD), and the pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC).  He is also the Clinical Lead for the Provincial Drug Reimbursement Programs (PDRP) at Cancer Care Ontario (CCO).